A narrative review reports that polysaccharides, bioactive components found across higher plants and other organisms, have shown potential biological effects in polycystic ovary syndrome (PCOS), including lower blood glucose, reduced serum testosterone, improved menstrual regularity, weight loss and suppression of abnormal inflammation. The findings combine evidence from preclinical and clinical studies rather than results from a new trial, and the review describes polysaccharides as potential complementary therapeutic agents rather than established treatments.
PCOS is characterized in the review as a prevalent and clinically significant reproductive-endocrine disorder among women of childbearing age. The authors organize the evidence around several manifestations of the condition, including insulin resistance, obesity, inflammation and disturbances in sex-hormone balance. Polysaccharides are of interest because earlier studies have reported anti-inflammatory, immunomodulatory, hypoglycemic, lipid-lowering and anti-obesogenic activities. Those broader biological properties provide the rationale for examining whether particular polysaccharides could affect more than one feature of PCOS.
Across the studies summarized by the review, polysaccharides were associated with improvements in menstrual irregularities, body weight, blood glucose and serum testosterone, together with reduced aberrant inflammation. The authors also propose that these compounds could help alleviate clinical manifestations of PCOS, ameliorate insulin resistance and obesity, attenuate inflammatory responses and restore sex-hormone homeostasis. These are the review’s reported potential effects and its interpretation of the cumulative evidence; they do not amount to a uniform finding that every polysaccharide produces every listed outcome.
Because this is a narrative review, its conclusions synthesize evidence from different experimental and clinical settings rather than provide a new controlled comparison or a single pooled estimate of efficacy. The accessible abstract does not identify the individual compounds, doses, formulations, participant characteristics, trial designs or adverse-event results associated with the reported outcomes. It therefore does not support treating evidence for one polysaccharide preparation as interchangeable with evidence for another, or drawing conclusions about comparative effectiveness and long-term safety. Within the scope supported by the review, polysaccharides emerge as candidates for further evaluation as complementary approaches to PCOS management, but the available material does not establish a standardized clinical therapy.
Subject of Research: Reported biological effects of polysaccharides in polycystic ovary syndrome
Article Title: Roles and Biological Effects of Polysaccharides in Polycystic Ovary Syndrome: A Narrative Review
Article References: Ding, N., Sun, C., Wang, H., Lv, Y., Han, Y., & Kuang, H. (2026). Roles and Biological Effects of Polysaccharides in Polycystic Ovary Syndrome: A Narrative Review. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02232-2
Image Credits: AI Generated
DOI: 10.1007/s43032-026-02232-2
Keywords: polycystic ovary syndrome, polysaccharides, insulin resistance, inflammation, obesity, blood glucose, serum testosterone, menstrual irregularity, narrative review, reproductive endocrinology, Roles, Biological
Cite Scienmag News
Ophelia Keating. (October 20, 2026). Review Maps Polysaccharide Effects in Polycystic Ovary Syndrome. Scienmag. https://scienmag.com/review-maps-polysaccharide-effects-in-polycystic-ovary-syndrome/
Ophelia Keating. "Review Maps Polysaccharide Effects in Polycystic Ovary Syndrome." Scienmag, 20 October 2026, https://scienmag.com/review-maps-polysaccharide-effects-in-polycystic-ovary-syndrome/. Accessed 20 October 2026.
Ophelia Keating. "Review Maps Polysaccharide Effects in Polycystic Ovary Syndrome." Scienmag. October 20, 2026. https://scienmag.com/review-maps-polysaccharide-effects-in-polycystic-ovary-syndrome/

